February 20, 2008 - Derma Sciences Inc. announced today that four abstracts detailing the clinical usage of its newly released MEDIHONEY Wound & Burn Dressings with Active Leptospermum Honey were accepted for presentation at the upcoming annual American Professional Wound Care Association conference, held this year between March 6 - 9 in Forth Worth, TX.
Additionally, the company has announced that the use of MEDIHONEY Dressings is a topic on the general session agenda for the conference.
The abstracts include the following:
“Chronic Lower Extremity Ulceration -- Use of a Leptospermum Impregnated Alginate to Accelerate Wound Closure” by Matt Regulski, DPM, Toms River Foot and Ankle Surgical Associates, NJ
“Clinical Application of Absorbent Calcium Alginate Dressing Pads, Containing Manuka (Leptospermum) Honey, in Infected Lower Extremity Venous Ulcers” by Paul Kesselman, DPM, Brooklyn, NY
“Favorable Treatment Outcomes of Chronic Leg Ulcers with the Use of a New Leptospermum Honey Alginate Dressing” by Paul A. Ligouri, M.D. and Kim L. Peters, RN, CWS, Whittier Rehabilitation Hospital, Haverhill, MA.
“Utilizing Leptospermum Honey Alginate in Treatment of Recalcitrant Lower Extremity Ulcers” Steven J. Kavros, DPM, Mayo Clinic, Rochester, MN.
MEDIHONEY is one of the first FDA-cleared honey-based dressing for use on chronic wounds and burns.
For more information: www.dermasciences.com